Abstract
Greystone Research Associates is pleased to announce the publication of a new
market study. Microneedle Drug Delivery Patches, Syringes & Systems: Devices,
Players, Markets and Forecasts is a comprehensive evaluation and analysis of
the technology, products and participants providing the driving force behind
this evolving segment of the healthcare sector.
The study is designed to provide drug company decision makers, drug delivery
developers, device designers, healthcare marketers, and supply chain
participants with a detailed understanding of the economics, technologies,
healthcare segments and commercial opportunities for microneedle arrays and
devices in the delivery of therapeutic drugs. Provider organization business
managers, healthcare administrators and investors will also benefit from this
study.
Converging Technology that Addresses Unmet Medical Needs
Microneedle technology is attaining commercial viability at a time when drug
developers are faced with new challenges as they assess ways to administer new
classes of compounds with significant therapeutic potential. The widespread
availability of rapid throughput screening is accelerating the discovery of
new drugs, a significant number of which are large-molecule therapeutic
compounds that cannot tolerate passage through the digestive system, requiring
pharmaceutical companies to forego oral formulations and select alternate
routes of administration.
Microneedle technology has the potential address the growing trend toward
selfadministration by allowing the precise placement of therapeutic agents at
prescribed locations below the skin. But before microneedles find widespread
use, developers must refine the techniques for large-scale manufacturing and
for optimally inserting microneedles into the skin, and advance the design
integration of microneedles into commercially viable drug delivery systems.
Table of Contents
Executive Summary
Microneedle Medical Market Overview
- Drug Delivery & Self-Administration
- Chronic Conditions & Dosing Frequency
- Patient Safety and Compliance
- Microneedle Market Drivers
- The Trend to Minimally Invasive Medicine
- Shifting Patient Demographics
- Managed Care Initiatives
- Government Technology Transfer Programs
Microneedle Design & Technology
- Microneedle Form Factors
- Solid Microneedles
- Hollow Microneedles
- Coated Microneedles
- Dissolvable Microneedles
- Microneedle Arrays & Array Geometries
- Microneedle Manufacturing
- Material Selection Issues
- Fabrication Techniques
- Emerging Fabrication Methods
Medical Microneedles - Assessments & Commercialization Prospects
- Solid Microneedle Arrays
- BA058 Patch
- ClickSoft
- DrugMAT
- Functional Microarray (FMA)
- MicroCor
- Micropatch
- Micropoint Patch
- sMTS
- ZP Patch
- Hollow Microneedle Arrays
- Micro-Trans
- Silicon Microneedles
- Phase Transition Microneedle Patch
- Dissolving Microneedle Chip
- Syringe Mounted Microneedles
- AdminPatch
- MicronJet
- NanoJect
- Soluvia
- Programmable Microneedle Patch
Near-Terms Markets - Sector Assessments and Forecasts
- Dermatology/Cosmetic Surgery
- Genetic/DNA/Nucleotide Therapeutics
- Osteoporosis
- Reproductive Medicine
- Vaccines
Company Profiles
Microneedle Drug Delivery Patches, Syringes & Systems: Devices, Players, Markets and Forecasts published by Greystone Research Associates in September 12, 2012. This report price starts from US $ 2850.